Modulation of Clostridioides difficile virulence by metabolites derived from probiotic consortia and genetically edited strains
{{output}}
Clostridioides difficile infection (CDI) continues to pose a significant clinical and biotechnological challenge, primarily driven by antimicrobial resistance and frequent recurrence. Emerging strategies are shifting the therapeutic focus from pathobiont eradi... ...
